Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | UGP2 |
| Upstream (Parents) |
|---|
| (<<) TTPA → UGP2 |
| (<<) GGCX → UGP2 |
| Downstream (Children) |
|---|
| UGP2 → AVPR1A (>>) |
| UGP2 → MTSS1 (>>) |
| UGP2 → ENO3 (>>) |
| UGP2 → PLAGL1 (>>) |
| UGP2 → SC65 (>>) |
| UGP2 → BLVRB (>>) |
| UGP2 → NQO2 (>>) |
| UGP2 → SLC25A6 (>>) |
| UGP2 → TAF4B (>>) |
| UGP2 → RPS9 (>>) |
| UGP2 → RPL29P11///RPL29P15///RPL29P9///RPL29P26///RPL29P6///RPL29P4///RPL29P31///RPL29P12///RPL29 (>>) |
| UGP2 → IMPDH2 (>>) |
| UGP2 → TMED3 (>>) |
| UGP2 → RPL36AP51///RPL36A (>>) |
| UGP2 → HPS5 (>>) |
| UGP2 → LPCAT3 (>>) |
